These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 5617942
21. [Use of decaris in the complex treatment of destructive pulmonary tuberculosis]. German AK, Logiĭko VL. Vrach Delo; 1981 Aug; (8):81-3. PubMed ID: 7269517 [No Abstract] [Full Text] [Related]
22. [Results of rondomycin treatment of nonspecific respiratory tract diseases and complications of pulmonary tuberculosis]. Mysakowska H, Pleszczyńska E, Grodzki S, Przemyska B, Sidor-Smaga M. Pol Tyg Lek; 1969 Oct 01; 24(45):1741-3. PubMed ID: 5364156 [No Abstract] [Full Text] [Related]
23. [Complex treatment of destructive pulmonary tuberculosis]. Shul'ga IA, Znosenko VA, Sukhorukova IS, Davydova GN, Surovtseva EIa, Shlapakova MA, Pelipas IG. Probl Tuberk Bolezn Legk; 2003 Oct 01; (7):29-31. PubMed ID: 12939873 [Abstract] [Full Text] [Related]
27. [Effectiveness of treatment of patients with recently detected pulmonary tuberculosis residing in a rural area]. Aseev DD, Al'tshuler NS, Vinogradova RG, Vasil'eva IuS. Probl Tuberk; 1966 Oct 01; 44(12):3-5. PubMed ID: 6003077 [No Abstract] [Full Text] [Related]
28. [L-forms of Mycobacterium tuberculosis during chemotherapy of patients with chronic destructive pulmonary tuberculosis]. Karachunskiĭ MA, Dorozhkova IR, Kaminskaia AA, Abdullaeva ET. Probl Tuberk; 1983 Jul 01; (7):38-43. PubMed ID: 6415651 [No Abstract] [Full Text] [Related]
29. [Characteristics of the clinical aspects of fibrous-cavernous pulmonary tuberculosis during antibacterial therapy]. Tarasov GG. Vrach Delo; 1968 Oct 01; 10():71-6. PubMed ID: 5740336 [No Abstract] [Full Text] [Related]
30. [Anthranylic acid derivatives in the complex treatment of pulmonary tuberculosis in late middle-aged and elderly patients]. Filippova ES. Probl Tuberk; 1984 May 01; (5):68-9. PubMed ID: 6739481 [No Abstract] [Full Text] [Related]
31. [The efficacy of the intermittent method in the use of tuberculostatic preparations of the 1st and 2nd series in the treatment of patients with destructive forms of pulmonary tuberculosis]. Navrotskiĭ VV, Pertsovskiĭ AI, Belogurova VP. Probl Tuberk; 1968 May 01; 46(11):39-43. PubMed ID: 5711714 [No Abstract] [Full Text] [Related]
35. [Nicotinic acid metabolism in patients with pulmonary tuberculosis before therapy and during antibacterial therapy]. Belozorov PT, Vil'nianskiĭ LI, Miroshnikova VI. Probl Tuberk; 1967 May 01; 45(4):55-9. PubMed ID: 5606806 [No Abstract] [Full Text] [Related]
36. [Fenazide efficiency in combined chemotherapy of new and relapsing pulmonary tuberculosis]. Mishin VIu, Chukanov VI, Golyshevskaia VI, Grigor'ev IuG. Probl Tuberk; 2000 May 01; (3):25-8. PubMed ID: 10900980 [No Abstract] [Full Text] [Related]
39. [Treatment of pulmonary tuberculosis in patients with drug dependence]. Zadremaĭlova TA, Aksenova KI. Probl Tuberk Bolezn Legk; 2003 May 01; (7):31-3. PubMed ID: 12939874 [Abstract] [Full Text] [Related]
40. [Clinical study on the therapy of pulmonary tuberculosis with Capreomycin]. Saishin Igaku; 1966 Jan 01; 21(1):164-77. PubMed ID: 5965936 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]